Report Categories
View AllRecent Articles
View All
Valero Energy Corporation VLO Bullish PreEarnings Outlook Signals Strong Q1 2026 Beat Potential
Is Brixmor BRX stock appealing for longterm investors Q4 2025 Earnings Beat Estimates
Is Roblox Corporation RBLX stock worth entering at this stage Q1 2026 Earnings Beat Estimates
PMTW PennyMac posts 197 percent Q4 2025 EPS beat with shares edging higher following the earnings release
Oxford OXSQ Declines 489 Amid Market Weakness 20260515
Molson TAP Climbs 094 Resistance at 4326 in Focus 20260515
Bowman BWMN Stock Jumps 087 Approaching 3300 20260518
AlphaSense Highlights 10 Major Mergers and Acquisitions Reshaping the Market
Stifel Boosts Nvidia Price Target to 282 Following Strong Earnings Performance
SUNS Q1 2026 Earnings Profitability Surges Past Expectations with 23 EPS Beat
Consumer Sentiment Plunges to Record Low in May as Iran War Drives Gas Prices Higher
Nuvalent Inc NUVL Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline
Kevin Warsh Takes Helm at Federal Reserve Markets Eye Policy Shift Amid Inflation and Geopolitical Risks
GMR Airports ONGC Coal India Among Stocks in Focus as Gift Nifty Signals Muted Opening
ADP Private Payrolls Rise by 109000 in April Surpassing Forecasts
Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Regulatory Blocker
US Jobs Report Beats Expectations But Raises Economic Concerns
Critical Medicines Act Poised to Reshape Pharmaceutical Manufacturing and Supply Resilience in Europe
BingEx FLX Q1 2026 Earnings Net Loss Reported Amid Limited Disclosure
BULL Q1 2026 Earnings EPS Misses Estimates by Over 50 Stock Declines
MOMO Q4 2025 Earnings EPS Misses Estimates by 4529 as Stock Rises 151
JBL Q1 2026 Earnings Solid EPS Beat Drives Positive Market Reaction
FirstCash Holdings FCFS Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency
CelSci Corporation CVM Q4 2024 Earnings Narrower Loss Beats Estimates Stock Slips
Immix Biopharma IMMX Edges Lower in Consolidation Phase Eyes Key Support at 829
Abbott Laboratories ABT Retreats Key Support Levels in Focus Amid Broader Market Pressure
Contineum Therapeutics CTNM Declines 355 Testing Key Support at 1317
Maravai LifeSciences MRVI Surges 469 as Biotech Sentiment Improves
Elicio Therapeutics ELTX Holds Near Resistance as Therapeutic Pipeline Momentum Builds